Table 3.
Days to Relapse and Treatment Utilization by Psychiatric History
| Outcomes | Anxiety (AH+) M(SE)a | Depression (DH+) M(SE)a | Any Psychiatric Diagnosis (PH+) M(SE)a | No Psychiatric Diagnosis (PH-) M(SE)a |
|---|---|---|---|---|
| Days to relapse | 49.0 (6.8) | 52.2 (5.3) | 51.1 (4.8) | 59.5 (5.0) |
| Days varenicline duration | 56.4 (3.0)* | 60.0 (2.4)* | 59.4 (2.2)* | 68.5 (2.2) |
| Total phone counseling callsb | 3.3 (0.2) | 3.5 (0.1) | 3.4 (0.1) | 3.5 (0.1) |
| Total web log-insc | 4.7 (9.9) | 3.7 (9.2) | 3.9 (9.3) | 5.6 (21.0) |
| Duration of phone counseling (total minutes) | 46.0 (4.1) | 47.6 (3.0) | 47.1 (2.8) | 43.4 (2.4) |
| Duration web treatment (total minutes) | 94.3 (1.1) | 46.7 (9.2) | 65.6 (0.7) | 81.8 (1.6) |
M = mean; SE = standard error.
Total number of proactive and reactive phone calls completed. Maximum proactive calls (i.e., counselor initiated calls to participants) attempted to be completed was 5 and was limited to participants in Phone and Phone + Web treatment groups. Additional participant initiated (i.e., reactive) calls allowed among all participants.
Total number of log-ins to online treatment program. Applicable to participants in Web and Phone + Web groups.
P ≤ .01 comparison to persons with no psychiatric diagnosis (PH-) in analyses that are unadjusted for covariates or multiple comparisons. Results of all comparisons were unchanged controlling for treatment group and baseline differences in gender and marital status.